Search filters

List of works by Chad Bousman

"Black box" pharmacogenetic decision-support tools in psychiatry

scientific article published on 24 January 2020

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

scientific article published on 27 November 2012

Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort

scientific article published on 5 January 2012

Antidepressant pharmacogenetics

scientific article published on January 2014

Assessing neuropsychological performance in a migrant farm working Colonia in Baja California, Mexico: a feasibility study.

scientific article

Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.

scientific article published on 26 June 2013

Chronic illness histories of adults entering treatment for co-occurring substance abuse and other mental health disorders

scientific article published on 15 December 2011

Correlation of major depressive disorder symptoms with FKBP5 but not FKBP4 expression in human immunodeficiency virus-infected individuals

scientific article published on October 2010

Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings

scientific article

Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings

scientific article

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis. ⬇️

scientific article published on 30 April 2013

Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendees

scientific article published on 4 October 2013

Erythrocyte polyunsaturated fatty acid composition is associated with depression and FADS genotype in Caucasians.

scientific article

Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis

scientific article

Formative Assessment of ARM-U: A Modular Intervention for Decreasing Risk Behaviors Among HIV-Positive and HIV-Negative Methamphetamine-Using MSM

scientific article

Functional brain networks in treatment-resistant schizophrenia.

scientific article

G-protein β3 subunit genetic variation moderates five-year depressive symptom trajectories of primary care attendees

scientific article published on 24 April 2014

Genetic association studies of methamphetamine use disorders: A systematic review and synthesis

scientific article published on December 2009

High impact child abuse may predict risk of elevated suicidality during antidepressant initiation

scientific article published on December 2013

Homelessness and neuropsychological impairment: preliminary analysis of adults entering outpatient psychiatric treatment

scientific article published in November 2010

Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine

scientific article published on January 2010

Investigation of peripheral complement factors across stages of psychosis

scientific article published on 06 December 2018

Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.

scientific article published on 24 January 2013

Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.

scientific article

Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: A five-year prospective cohort study of primary care attendees

scientific article published on 4 October 2013

Negative Symptoms of Psychosis Correlate with Gene Expression of the Wnt/β-Catenin Signaling Pathway in Peripheral Blood

scientific article published on January 2013

Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV

scientific article

O1.6. INCREASED COMPLEMENT FACTORS C3 AND C4 IN SCHIZOPHRENIA AND THE EARLY STAGES OF PSYCHOSIS: IMPLICATIONS FOR CLINICAL SYMPTOMATOLOGY AND CORTICAL THICKNESS.

scientific article published in April 2018

Oestrogen alpha-receptor variant and two-year memory decline in midlife Australian women

scientific article

Parenting × Brain Development interactions as predictors of adolescent depressive symptoms and well-being: Differential susceptibility or diathesis-stress?

scientific article published on 01 February 2020

Pharmacogenetic Testing Options Relevant to Psychiatry in Canada

scientific article published on 17 February 2020

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression

scientific article published in September 2013

Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood

scientific article published on October 2010

Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence

scientific article

Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioning

scientific article published on 25 August 2010

Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples

scientific article

Psychomotor depressive symptoms may differentially respond to venlafaxine

scientific article published in May 2013

Reply to Dawes et al

scientific article published on 19 May 2020

Risk and resilience brain networks in treatment-resistant schizophrenia.

scientific article

The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study

scientific article

Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology

scientific article published on 26 August 2020

Paulina is supported by:

About Paulina

Help